SkillClick
FoundersClick
added new post
Shares of AbbVie plummeted Monday after the company said its schizophrenia drug Emraclidine missed key goals in a pair of trials.
Shares of AbbVie plummeted Monday after the company said its schizophrenia drug Emraclidine missed key goals in a pair of trials.
0 Comments
0 Shares
Please log in to Recommend, share and comment!